Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05572983 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

Name: Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype — clinical trial record (NCT05572983)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusUnknown

PhasePhase 2

SponsorSun Yat-sen University

Started2022-09-01

View on ClinicalTrials.gov ↗

Record status

This record was last updated October 10, 2022 (before its estimated September 1, 2024 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06

Trial status changed: Recruiting → Unknown

Sun Yat-sen University

609 trials monitored

See 13 trials at risk

Non-Hodgkin Lymphoma

1,512 trials monitored

See 79 trials at risk

This is a prospective, open-label, single arm, multicenter clinical study to evaluate the safety, tolerability, efficacy of chidamide in combination with CHOP in previously untreated peripheral T-cell lymphoma with follicular helper of T cell phenotype

Trial Details

NCT Number	NCT05572983
Lead Sponsor	Sun Yat-sen University
Conditions	Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
Enrollment	47 participants
Start Date	2022-09-01
Primary Completion	2024-09-01 (estimated)
Study Completion	2026-09-01 (estimated)
Updated on ClinicalTrials.gov	2022-10-10